4-Thiophenoxy-N-(3,4,5-Trialkoxyphenyl)Pyrimidine-2-Amines as Potent and Selective Inhibitors of the T-Cell Tyrosine Kinase p56lck

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|11|6|747-753

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.11, Iss.6, 2004-03, pp. : 747-753

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Src Homology-2 Domains (SH2 Domains) of the Protein Tyrosine Kinase p56 lck Structure, Mechanism and Drug Design

By  

Current Drug Targets, Vol. 1, Iss. 4, 2000-01 ,pp. : 365-386

Bentham Science Publishers

Access to resources Recommend Favorite

Rational Design of Potent and Selective EGFR Tyrosine Kinase Inhibitors as Anticancer Agents

By  

Current Cancer Drug Targets, Vol. 1, Iss. 2, 2001-08 ,pp. : 129-140

Bentham Science Publishers

Access to resources Recommend Favorite

Design of Selective Inhibitors of Tyrosine Kinase 2

By  

Letters in Drug Design & Discovery, Vol. 2, Iss. 7, 2005-11 ,pp. : 507-515

Bentham Science Publishers

Access to resources Recommend Favorite

Selective tyrosine kinase inhibitors

By Wilkinson S.E.   Harris W.  

Expert Opinion on Emerging Drugs, Vol. 5, Iss. 3, 2000-10 ,pp. : 287-297

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of p56lck: assessing their potential as tools for manipulating T-lymphocyte activation

By Dowden J.   Ward S.G.  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 2, 2001-02 ,pp. : 295-306

Informa Healthcare

Access to resources Recommend Favorite